Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Oculus Innovative Sciences Inc Announces Full Exercise Of Underwriters' Over-Allotment Option
Oculus Innovative Sciences Inc announced the full exercise of the over-allotment option granted to the representative of the underwriters to purchase an additional 1,125,000 shares of common stock, at a public offering price of $0.40 per share in connection with its previously announced underwritten public offering of 7,500,000 shares of common stock, bringing total gross proceeds from the offering to approximately $3.5 million. Aegis Capital Corp. is acting as the sole book-running manager for this offering. Dawson James Securities, Inc. is acting as a co-manager for the offering.
Latest Developments for Oculus Innovative Sciences Inc
- Oculus Innovative Sciences Inc Announces Closing of Public Offering of 8,625,000 Shares of Common Stock
- Oculus Innovative Sciences Inc Announces Management Change-Form 8-K
- Oculus Innovative Sciences Inc Announces Plan To Spin Off Biotechnology Business
- Oculus Innovative Sciences Inc To Create Subsidiary For Anti-Infective Drug Assets
Latest Key Developments in Pharmaceuticals
- Nattopharma ASA Maintains FY 2013 Revenue Guidance
- Grifols SA’s Study Demonstrates Higher Dose Of PROLASTIN-C Increases Levels Of Alpha1-PI To Within Normal Range In Patients With AAT Deficiency-DJ
- Protalex Inc Announces Positive Interim Review of Phase 1b Trial Of PRTX-100 in Rheumatoid Arthritis By Independent Data Safety Monitoring Committee
- Pfizer Inc Announces Plan For Split-Off Of Zoetis Inc
- Share this
- Link this
- Digg this


Follow Reuters